|
Acute Promyelocytic Leukemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
RIF and ATO showed similar effects on the recovery of coagulopathy in APL patients.
|
29232592 |
2018 |
|
Blood Coagulation Disorders
|
0.010 |
Biomarker
|
group |
BEFREE |
RIF and ATO showed similar effects on the recovery of coagulopathy in APL patients.
|
29232592 |
2018 |
|
Blood Protein Measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genomic atlas of the human plasma proteome.
|
29875488 |
2018 |
|
Chronic endometritis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Recent evidences suggest that in apparently normal endometria, RIF may associate with molecular and functional changes in the uterus such as abnormal endometrial microbiota, including the presence of chronic endometritis, poor synchronization between the blastocyst and endometrium, and/or excessive uterine peristalsis.
|
29889670 |
2018 |
|
Coinfection
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
The Xpert® MTB/RIF assay is being implemented as a substitute for sputum smear microscopy (SSM) in many low and high tuberculosis (TB) burden countries, including Brazil, a country with low multidrug resistance and moderate human immunodeficiency virus co-infection rates.
|
27084814 |
2016 |
|
Complicated malaria
|
0.010 |
Biomarker
|
disease |
BEFREE |
Here, antibody subclass responses to a recombinant RIFIN protein (RIF-29) in 116 Ghanaian children were determined by ELISA to investigate the relationship between severe malaria and anti-RIF-29 antibodies.
|
16679041 |
2006 |
|
Disseminated Intravascular Coagulation
|
0.010 |
Biomarker
|
disease |
BEFREE |
RIF had a potential beneficial effect in accelerating the recovery of thrombocytopenia and hypofibrinogenemia for subclinical DIC patients.
|
29232592 |
2018 |
|
Endometriosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Abbreviations: AMs: adenomyosis; EMs: endometriosis; RIF: recurrent implantation failure; miRNAs: microRNAs; lncRNAs: Long non-coding RNAs; RT-qPCR: real-time quantitative PCR; ESCs: endometrial stromal cells; EECs: endometrial epithelial cells; BFE: free binding energy; PCDHB9: protocadherin beta 9; PARVG: parvin gamma; MAPK6: mitogen-activated protein kinase 6; LAF1: lymphocyte function-associated antigen 1.
|
30649983 |
2019 |
|
Eosinophil count procedure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
|
Eosinophilic esophagitis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Finally, we find that RHOF is upregulated in eosinophilic esophagitis, an important esophageal inflammatory disease in humans.
|
30998758 |
2019 |
|
Extensively Drug-Resistant Tuberculosis
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
We conclude that the remnants of samples processed for the Xpert assay can be used in PCRs to find mutations associated with the resistance to the additional drugs that defines MDR and XDR-TB and to study molecular epidemiology without the need for culturing or a biosafe infrastructure.
|
28446574 |
2017 |
|
Fibrinogen Deficiency
|
0.010 |
Biomarker
|
disease |
BEFREE |
RIF had a potential beneficial effect in accelerating the recovery of thrombocytopenia and hypofibrinogenemia for subclinical DIC patients.
|
29232592 |
2018 |
|
Hematologic Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
Real-time PCR investigation for deletion of genes BCL7A, SMAC/DIABLO, and RHOF-three tumor suppressor genes with a putative role in hematological malignancies-demonstrated that they were deleted in 9, 10, and 13 cases, respectively.
|
18663754 |
2008 |
|
Hepatitis
|
0.010 |
Biomarker
|
group |
BEFREE |
Sputum samples tested on Xpert for MTB/RIF assay and blood specimens collected for HIV and hepatitis serology.
|
31801496 |
2019 |
|
Hepatitis A
|
0.010 |
Biomarker
|
disease |
BEFREE |
Sputum samples tested on Xpert for MTB/RIF assay and blood specimens collected for HIV and hepatitis serology.
|
31801496 |
2019 |
|
hiv-infection/aids
|
0.010 |
Biomarker
|
disease |
BEFREE |
Cost Analysis of Tuberculosis Diagnosis in Cambodia with and without Xpert<sup>®</sup> MTB/RIF for People Living with HIV/AIDS and People with Presumptive Multidrug-resistant Tuberculosis.
|
29862440 |
2018 |
|
Human immunodeficiency virus (HIV) II infection category B1
|
0.050 |
Biomarker
|
disease |
BEFREE |
The introduction of Xpert MTB/RIF assay (Xpert) has significantly improved diagnosis of Tuberculosis (TB) in resource limited human immunodeficiency virus (HIV) endemic settings.
|
29284421 |
2017 |
|
Human immunodeficiency virus (HIV) II infection category B1
|
0.050 |
Biomarker
|
disease |
BEFREE |
Sputum samples tested on Xpert for MTB/RIF assay and blood specimens collected for HIV and hepatitis serology.
|
31801496 |
2019 |
|
Human immunodeficiency virus (HIV) II infection category B1
|
0.050 |
Biomarker
|
disease |
BEFREE |
We assessed the performance of alternative specimen collection methods for tuberculosis diagnosis in HIV-infected children using Xpert MTB/RIF (Xpert).
|
26908804 |
2016 |
|
Human immunodeficiency virus (HIV) II infection category B1
|
0.050 |
Biomarker
|
disease |
BEFREE |
The GX results of Primestore-stored samples were similar to those found in the fresh sputum of non-HIV infected patients, but GX-positivity was lower in HIV-infected patients.
|
31817201 |
2019 |
|
Human immunodeficiency virus (HIV) II infection category B1
|
0.050 |
GeneticVariation
|
disease |
BEFREE |
Our results show high rates of DR-TB in Nigerian HIV-infected individuals (7.0% for rifampin [RIF] and 9.3% for RIF or isoniazid [INH]).
|
22740709 |
2012 |
|
Hydrocephalus
|
0.010 |
Biomarker
|
disease |
BEFREE |
There was a significant association between CSF GeneXpert and Mantoux test (P = 0.002), CSF cell type >50% lymphocytes (P = 0.005) and CSF protein >100 mg/dl (P = 0.025) along with CT hydrocephalus (P = 0.021), granuloma (P = 0.009) and basal exudates (P = 0.025).
|
31359250 |
2019 |
|
Hypofibrinogenemia
|
0.010 |
Biomarker
|
disease |
BEFREE |
RIF had a potential beneficial effect in accelerating the recovery of thrombocytopenia and hypofibrinogenemia for subclinical DIC patients.
|
29232592 |
2018 |
|
Immune Reconstitution Inflammatory Syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
Five cases were false-positive by Xpert MTB/RIF in patients with nontuberculous mycobacteria, old PTB scar, and immune reconstitution syndrome.
|
28475796 |
2017 |
|
Immune reconstitution syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
Five cases were false-positive by Xpert MTB/RIF in patients with nontuberculous mycobacteria, old PTB scar, and immune reconstitution syndrome.
|
28475796 |
2017 |